GlassScriptPhysician profile
Weston Charles Angermeier
NPI 1174020978
$6,680.34
in general payments reported to CMS, 2019-2025
23 companies · $521 in 2025
The $521 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,073 · 2020: $125 · 2021: $791 · 2022: $2,263 · 2023: $1,168 · 2024: $738 · 2025: $521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,427.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,537.79 | 2019-2025 | Bioskin, Citrefix, Actishield |
| Smith+Nephew, INC. | $727.98 | 2019-2023 | Oasis, Grafix, Renasys Go V2 Home |
| Horizon Therapeutics Plc | $459.47 | 2019-2023 | Krystexxa |
| Abbvie INC. | $372.16 | 2023-2025 | Dalvance |
| Kerecis Limited | $320.90 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Paratek Pharmaceuticals, INC. | $193.51 | 2023-2025 | Nuzyra |
| Convatec INC. | $186.19 | 2023-2025 | |
| Amgen INC. | $124.98 | 2024 | Krystexxa |
| Pacira Pharmaceuticals Incorporated | $118.46 | 2022 | |
| Wright Medical Technology, INC. | $110.64 | 2019-2020 | |
| Boston Scientific Corporation | $99.61 | 2022 | |
| Fortis Surgical, LLC | $78.70 | 2021-2024 | |
| Trice Medical, INC. | $61.57 | 2023 | |
| Lifenet Health | $59.73 | 2024-2025 | Theragenesis Wound Matrix |
| Integra Lifesciences Corporation | $47.00 | 2020-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $44.09 | 2025 | Intellis Adaptivestim, Inceptiv |
| Zimmer Biomet Holdings, INC. | $43.75 | 2021 | |
| In2bones USA, LLC | $22.36 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $21.41 | 2025 | |
| Reprise Biomedical, INC. | $17.21 | 2025 | Miro3d |
| Heron Therapeutics, INC. | $14.87 | 2022 | |
| Acumed LLC | $11.21 | 2019 | |
| Organogenesis INC. | $6.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Weston Angermeier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.